APO Research
Talk to an analyst

APO RESEARCH · REPORT

Teriflunomide Tablets

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Teriflunomide Tablets Market Outlook and Growth Opportunities 2026

27 December 2025202 pages

Choose your research edition.

Industry ResearchTeriflunomide Tablets Industry Research Report 2026133 pages · $2,950 USDIndustry Growth & TrendsGlobal Teriflunomide Tablets Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Teriflunomide Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Teriflunomide Tablets Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Teriflunomide Tablets Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Teriflunomide Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Teriflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Teriflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Teriflunomide Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Teriflunomide Tablets market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Teriflunomide Tablets market include Teva, CGeneTech (Suzhou, China), Nanjing Healthnice Pharmaceutical, Mylan, Cisen Pharmaceutical, Zydus, Viatris, SOLA Pharmaceuticals and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Teriflunomide Tablets market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Teriflunomide Tablets and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Teriflunomide Tablets sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Teriflunomide Tablets market size, projected growth trends, production technologies, key applications, and end-use industries.

Teriflunomide Tablets Segment by Company

Teva

CGeneTech (Suzhou, China)

Nanjing Healthnice Pharmaceutical

Mylan

Cisen Pharmaceutical

Zydus

Viatris

SOLA Pharmaceuticals

Sanofi

Sandoz

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

Camber Pharmaceuticals

Aurobindo Pharma

Apotex

Alembic

Accord Healthcare

Teriflunomide Tablets Segment by Type

7mg per Tablet

14mg per Tablet

Teriflunomide Tablets Segment by Application

Hospital and Clinic

Pharmacy

Other

Teriflunomide Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Teriflunomide Tablets status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Teriflunomide Tablets market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Teriflunomide Tablets significant trends, drivers, influence factors in global and regions.

6. To analyze Teriflunomide Tablets competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Teriflunomide Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Teriflunomide Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Teriflunomide Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Teriflunomide Tablets market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Teriflunomide Tablets industry.

Chapter 3: Detailed analysis of Teriflunomide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Teriflunomide Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Teriflunomide Tablets in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Teriflunomide Tablets Industry Trends Table 2. Teriflunomide Tablets Industry Drivers Table 3. Teriflunomide Tablets Industry Opportunities and Challenges Table 4. Teriflunomide Tablets Industry Restraints Table 5. Global Teriflunomide Tablets Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Teriflunomide Tablets Revenue Share by Company (2021-2026) Table 7. Global Teriflunomide Tablets Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Teriflunomide Tablets Sales Volume Share by Company (2021-2026) Table 9. Global Teriflunomide Tablets Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Teriflunomide Tablets Company Ranking, (2024-2026) & (USD Million) Table 11. Global Teriflunomide Tablets Key Company Manufacturing Base & Headquarters Table 12. Global Teriflunomide Tablets Company, Product Type & Application Table 13. Global Teriflunomide Tablets Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Teriflunomide Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 7mg per Tablet Table 18. Significant Companies of 14mg per Tablet Table 19. Global Teriflunomide Tablets Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Teriflunomide Tablets Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Teriflunomide Tablets Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Teriflunomide Tablets Sales Volume Share by Type (2021-2026) Table 23. Global Teriflunomide Tablets Sales Volume Share by Type (2027-2032) Table 24. Global Teriflunomide Tablets Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Teriflunomide Tablets Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Teriflunomide Tablets Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Teriflunomide Tablets Sales Value Share by Type (2021-2026) Table 28. Global Teriflunomide Tablets Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital and Clinic Table 30. Significant Companies of Pharmacy Table 31. Significant Companies of Other Table 32. Global Teriflunomide Tablets Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Teriflunomide Tablets Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Teriflunomide Tablets Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Teriflunomide Tablets Sales Volume Share by Application (2021-2026) Table 36. Global Teriflunomide Tablets Sales Volume Share by Application (2027-2032) Table 37. Global Teriflunomide Tablets Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Teriflunomide Tablets Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Teriflunomide Tablets Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Teriflunomide Tablets Sales Value Share by Application (2021-2026) Table 41. Global Teriflunomide Tablets Sales Value Share by Application (2027-2032) Table 42. Global Teriflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Teriflunomide Tablets Sales by Region (2021-2026) & (K Units) Table 44. Global Teriflunomide Tablets Sales Market Share by Region (2021-2026) Table 45. Global Teriflunomide Tablets Sales by Region (2027-2032) & (K Units) Table 46. Global Teriflunomide Tablets Sales Market Share by Region (2027-2032) Table 47. Global Teriflunomide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Teriflunomide Tablets Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Teriflunomide Tablets Sales Value Share by Region (2021-2026) Table 50. Global Teriflunomide Tablets Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Teriflunomide Tablets Sales Value Share by Region (2027-2032) Table 52. Global Teriflunomide Tablets Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Teriflunomide Tablets Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Teriflunomide Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Teriflunomide Tablets Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Teriflunomide Tablets Sales by Country (2021-2026) & (K Units) Table 57. Global Teriflunomide Tablets Sales Market Share by Country (2021-2026) Table 58. Global Teriflunomide Tablets Sales by Country (2027-2032) & (K Units) Table 59. Global Teriflunomide Tablets Sales Market Share by Country (2027-2032) Table 60. Global Teriflunomide Tablets Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Teriflunomide Tablets Sales Value Market Share by Country (2021-2026) Table 62. Global Teriflunomide Tablets Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Teriflunomide Tablets Sales Value Market Share by Country (2027-2032) Table 64. Teva Company Information Table 65. Teva Business Overview Table 66. Teva Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Teva Teriflunomide Tablets Product Portfolio Table 68. Teva Recent Development Table 69. CGeneTech (Suzhou, China) Company Information Table 70. CGeneTech (Suzhou, China) Business Overview Table 71. CGeneTech (Suzhou, China) Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. CGeneTech (Suzhou, China) Teriflunomide Tablets Product Portfolio Table 73. CGeneTech (Suzhou, China) Recent Development Table 74. Nanjing Healthnice Pharmaceutical Company Information Table 75. Nanjing Healthnice Pharmaceutical Business Overview Table 76. Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Product Portfolio Table 78. Nanjing Healthnice Pharmaceutical Recent Development Table 79. Mylan Company Information Table 80. Mylan Business Overview Table 81. Mylan Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Mylan Teriflunomide Tablets Product Portfolio Table 83. Mylan Recent Development Table 84. Cisen Pharmaceutical Company Information Table 85. Cisen Pharmaceutical Business Overview Table 86. Cisen Pharmaceutical Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Cisen Pharmaceutical Teriflunomide Tablets Product Portfolio Table 88. Cisen Pharmaceutical Recent Development Table 89. Zydus Company Information Table 90. Zydus Business Overview Table 91. Zydus Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Zydus Teriflunomide Tablets Product Portfolio Table 93. Zydus Recent Development Table 94. Viatris Company Information Table 95. Viatris Business Overview Table 96. Viatris Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Viatris Teriflunomide Tablets Product Portfolio Table 98. Viatris Recent Development Table 99. SOLA Pharmaceuticals Company Information Table 100. SOLA Pharmaceuticals Business Overview Table 101. SOLA Pharmaceuticals Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. SOLA Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 103. SOLA Pharmaceuticals Recent Development Table 104. Sanofi Company Information Table 105. Sanofi Business Overview Table 106. Sanofi Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Sanofi Teriflunomide Tablets Product Portfolio Table 108. Sanofi Recent Development Table 109. Sandoz Company Information Table 110. Sandoz Business Overview Table 111. Sandoz Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Sandoz Teriflunomide Tablets Product Portfolio Table 113. Sandoz Recent Development Table 114. Glenmark Pharmaceuticals Company Information Table 115. Glenmark Pharmaceuticals Business Overview Table 116. Glenmark Pharmaceuticals Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Glenmark Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 118. Glenmark Pharmaceuticals Recent Development Table 119. Dr. Reddy's Laboratories Company Information Table 120. Dr. Reddy's Laboratories Business Overview Table 121. Dr. Reddy's Laboratories Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Dr. Reddy's Laboratories Teriflunomide Tablets Product Portfolio Table 123. Dr. Reddy's Laboratories Recent Development Table 124. Camber Pharmaceuticals Company Information Table 125. Camber Pharmaceuticals Business Overview Table 126. Camber Pharmaceuticals Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Camber Pharmaceuticals Teriflunomide Tablets Product Portfolio Table 128. Camber Pharmaceuticals Recent Development Table 129. Aurobindo Pharma Company Information Table 130. Aurobindo Pharma Business Overview Table 131. Aurobindo Pharma Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Aurobindo Pharma Teriflunomide Tablets Product Portfolio Table 133. Aurobindo Pharma Recent Development Table 134. Apotex Company Information Table 135. Apotex Business Overview Table 136. Apotex Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Apotex Teriflunomide Tablets Product Portfolio Table 138. Apotex Recent Development Table 139. Alembic Company Information Table 140. Alembic Business Overview Table 141. Alembic Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Alembic Teriflunomide Tablets Product Portfolio Table 143. Alembic Recent Development Table 144. Accord Healthcare Company Information Table 145. Accord Healthcare Business Overview Table 146. Accord Healthcare Teriflunomide Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Accord Healthcare Teriflunomide Tablets Product Portfolio Table 148. Accord Healthcare Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Teriflunomide Tablets Distributors List Table 152. Teriflunomide Tablets Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Teriflunomide Tablets Product Image Figure 2. Global Teriflunomide Tablets Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Teriflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 4. Global Teriflunomide Tablets Sales (2021-2032) & (K Units) Figure 5. Global Teriflunomide Tablets Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Teriflunomide Tablets Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 7mg per Tablet Image Figure 10. 14mg per Tablet Image Figure 11. Global Teriflunomide Tablets Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Teriflunomide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Teriflunomide Tablets Sales Volume Share by Type (2021-2032) Figure 14. Global Teriflunomide Tablets Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Teriflunomide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Teriflunomide Tablets Sales Value Share by Type (2021-2032) Figure 17. Hospital and Clinic Image Figure 18. Pharmacy Image Figure 19. Other Image Figure 20. Global Teriflunomide Tablets Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Teriflunomide Tablets Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Teriflunomide Tablets Sales Volume Share by Application (2021-2032) Figure 23. Global Teriflunomide Tablets Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Teriflunomide Tablets Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Teriflunomide Tablets Sales Value Share by Application (2021-2032) Figure 26. Global Teriflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Teriflunomide Tablets Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Teriflunomide Tablets Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Teriflunomide Tablets Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Teriflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 31. North America Teriflunomide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Teriflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Teriflunomide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Teriflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Teriflunomide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Teriflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 37. South America Teriflunomide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Teriflunomide Tablets Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Teriflunomide Tablets Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Teriflunomide Tablets Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Teriflunomide Tablets Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Teriflunomide Tablets Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 7mg per Tablet
  • 14mg per Tablet
Applications
  • Hospital and Clinic
  • Pharmacy
  • Other
Companies covered
  • Teva
  • CGeneTech (Suzhou, China)
  • Nanjing Healthnice Pharmaceutical
  • Mylan
  • Cisen Pharmaceutical
  • Zydus
  • Viatris
  • SOLA Pharmaceuticals
  • Sanofi
  • Sandoz
  • Glenmark Pharmaceuticals
  • Dr. Reddy's Laboratories
  • Camber Pharmaceuticals
  • Aurobindo Pharma
  • Apotex
  • Alembic
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Teriflunomide Tablets Sales Value (2021-2032)
  4. 1.2.2 Global Teriflunomide Tablets Sales Volume (2021-2032)
  5. 1.2.3 Global Teriflunomide Tablets Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Teriflunomide Tablets Market Dynamics
  1. 2.1 Teriflunomide Tablets Industry Trends
  2. 2.2 Teriflunomide Tablets Industry Drivers
  3. 2.3 Teriflunomide Tablets Industry Opportunities and Challenges
  4. 2.4 Teriflunomide Tablets Industry Restraints
3 Teriflunomide Tablets Market by Company
  1. 3.1 Global Teriflunomide Tablets Company Revenue Ranking in 2025
  2. 3.2 Global Teriflunomide Tablets Revenue by Company (2021-2026)
  3. 3.3 Global Teriflunomide Tablets Sales Volume by Company (2021-2026)
  4. 3.4 Global Teriflunomide Tablets Average Price by Company (2021-2026)
  5. 3.5 Global Teriflunomide Tablets Company Ranking (2024-2026)
  6. 3.6 Global Teriflunomide Tablets Company Manufacturing Base and Headquarters
  7. 3.7 Global Teriflunomide Tablets Company Product Type and Application
  8. 3.8 Global Teriflunomide Tablets Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Teriflunomide Tablets Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Teriflunomide Tablets Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Teriflunomide Tablets Market by Type
  1. 4.1 Teriflunomide Tablets Type Introduction
  2. 4.1.1 7mg per Tablet
  3. 4.1.2 14mg per Tablet
  4. 4.2 Global Teriflunomide Tablets Sales Volume by Type
  5. 4.2.1 Global Teriflunomide Tablets Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Teriflunomide Tablets Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Teriflunomide Tablets Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Teriflunomide Tablets Sales Value by Type
  9. 4.3.1 Global Teriflunomide Tablets Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Teriflunomide Tablets Sales Value by Type (2021-2032)
  11. 4.3.3 Global Teriflunomide Tablets Sales Value Share by Type (2021-2032)
5 Teriflunomide Tablets Market by Application
  1. 5.1 Teriflunomide Tablets Application Introduction
  2. 5.1.1 Hospital and Clinic
  3. 5.1.2 Pharmacy
  4. 5.1.3 Other
  5. 5.2 Global Teriflunomide Tablets Sales Volume by Application
  6. 5.2.1 Global Teriflunomide Tablets Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Teriflunomide Tablets Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Teriflunomide Tablets Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Teriflunomide Tablets Sales Value by Application
  10. 5.3.1 Global Teriflunomide Tablets Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Teriflunomide Tablets Sales Value by Application (2021-2032)
  12. 5.3.3 Global Teriflunomide Tablets Sales Value Share by Application (2021-2032)
6 Teriflunomide Tablets Regional Sales and Value Analysis
  1. 6.1 Global Teriflunomide Tablets Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Teriflunomide Tablets Sales by Region (2021-2032)
  3. 6.2.1 Global Teriflunomide Tablets Sales by Region: 2021-2026
  4. 6.2.2 Global Teriflunomide Tablets Sales by Region (2027-2032)
  5. 6.3 Global Teriflunomide Tablets Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Teriflunomide Tablets Sales Value by Region (2021-2032)
  7. 6.4.1 Global Teriflunomide Tablets Sales Value by Region: 2021-2026
  8. 6.4.2 Global Teriflunomide Tablets Sales Value by Region (2027-2032)
  9. 6.5 Global Teriflunomide Tablets Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Teriflunomide Tablets Sales Value (2021-2032)
  12. 6.6.2 North America Teriflunomide Tablets Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Teriflunomide Tablets Sales Value (2021-2032)
  15. 6.7.2 Europe Teriflunomide Tablets Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Teriflunomide Tablets Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Teriflunomide Tablets Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Teriflunomide Tablets Sales Value (2021-2032)
  21. 6.9.2 South America Teriflunomide Tablets Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Teriflunomide Tablets Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Teriflunomide Tablets Sales Value Share by Country, 2025 VS 2032
7 Teriflunomide Tablets Country-level Sales and Value Analysis
  1. 7.1 Global Teriflunomide Tablets Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Teriflunomide Tablets Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Teriflunomide Tablets Sales by Country (2021-2032)
  4. 7.3.1 Global Teriflunomide Tablets Sales by Country (2021-2026)
  5. 7.3.2 Global Teriflunomide Tablets Sales by Country (2027-2032)
  6. 7.4 Global Teriflunomide Tablets Sales Value by Country (2021-2032)
  7. 7.4.1 Global Teriflunomide Tablets Sales Value by Country (2021-2026)
  8. 7.4.2 Global Teriflunomide Tablets Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Teriflunomide Tablets Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Teriflunomide Tablets Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Teriflunomide Tablets Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Teva Teriflunomide Tablets Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 CGeneTech (Suzhou, China)
  8. 8.2.1 CGeneTech (Suzhou, China) Company Information
  9. 8.2.2 CGeneTech (Suzhou, China) Business Overview
  10. 8.2.3 CGeneTech (Suzhou, China) Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 CGeneTech (Suzhou, China) Teriflunomide Tablets Product Portfolio
  12. 8.2.5 CGeneTech (Suzhou, China) Recent Developments
  13. 8.3 Nanjing Healthnice Pharmaceutical
  14. 8.3.1 Nanjing Healthnice Pharmaceutical Company Information
  15. 8.3.2 Nanjing Healthnice Pharmaceutical Business Overview
  16. 8.3.3 Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Nanjing Healthnice Pharmaceutical Teriflunomide Tablets Product Portfolio
  18. 8.3.5 Nanjing Healthnice Pharmaceutical Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Teriflunomide Tablets Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 Cisen Pharmaceutical
  26. 8.5.1 Cisen Pharmaceutical Company Information
  27. 8.5.2 Cisen Pharmaceutical Business Overview
  28. 8.5.3 Cisen Pharmaceutical Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Cisen Pharmaceutical Teriflunomide Tablets Product Portfolio
  30. 8.5.5 Cisen Pharmaceutical Recent Developments
  31. 8.6 Zydus
  32. 8.6.1 Zydus Company Information
  33. 8.6.2 Zydus Business Overview
  34. 8.6.3 Zydus Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Zydus Teriflunomide Tablets Product Portfolio
  36. 8.6.5 Zydus Recent Developments
  37. 8.7 Viatris
  38. 8.7.1 Viatris Company Information
  39. 8.7.2 Viatris Business Overview
  40. 8.7.3 Viatris Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Viatris Teriflunomide Tablets Product Portfolio
  42. 8.7.5 Viatris Recent Developments
  43. 8.8 SOLA Pharmaceuticals
  44. 8.8.1 SOLA Pharmaceuticals Company Information
  45. 8.8.2 SOLA Pharmaceuticals Business Overview
  46. 8.8.3 SOLA Pharmaceuticals Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 SOLA Pharmaceuticals Teriflunomide Tablets Product Portfolio
  48. 8.8.5 SOLA Pharmaceuticals Recent Developments
  49. 8.9 Sanofi
  50. 8.9.1 Sanofi Company Information
  51. 8.9.2 Sanofi Business Overview
  52. 8.9.3 Sanofi Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sanofi Teriflunomide Tablets Product Portfolio
  54. 8.9.5 Sanofi Recent Developments
  55. 8.10 Sandoz
  56. 8.10.1 Sandoz Company Information
  57. 8.10.2 Sandoz Business Overview
  58. 8.10.3 Sandoz Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Sandoz Teriflunomide Tablets Product Portfolio
  60. 8.10.5 Sandoz Recent Developments
  61. 8.11 Glenmark Pharmaceuticals
  62. 8.11.1 Glenmark Pharmaceuticals Company Information
  63. 8.11.2 Glenmark Pharmaceuticals Business Overview
  64. 8.11.3 Glenmark Pharmaceuticals Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Glenmark Pharmaceuticals Teriflunomide Tablets Product Portfolio
  66. 8.11.5 Glenmark Pharmaceuticals Recent Developments
  67. 8.12 Dr. Reddy's Laboratories
  68. 8.12.1 Dr. Reddy's Laboratories Company Information
  69. 8.12.2 Dr. Reddy's Laboratories Business Overview
  70. 8.12.3 Dr. Reddy's Laboratories Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Dr. Reddy's Laboratories Teriflunomide Tablets Product Portfolio
  72. 8.12.5 Dr. Reddy's Laboratories Recent Developments
  73. 8.13 Camber Pharmaceuticals
  74. 8.13.1 Camber Pharmaceuticals Company Information
  75. 8.13.2 Camber Pharmaceuticals Business Overview
  76. 8.13.3 Camber Pharmaceuticals Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Camber Pharmaceuticals Teriflunomide Tablets Product Portfolio
  78. 8.13.5 Camber Pharmaceuticals Recent Developments
  79. 8.14 Aurobindo Pharma
  80. 8.14.1 Aurobindo Pharma Company Information
  81. 8.14.2 Aurobindo Pharma Business Overview
  82. 8.14.3 Aurobindo Pharma Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Aurobindo Pharma Teriflunomide Tablets Product Portfolio
  84. 8.14.5 Aurobindo Pharma Recent Developments
  85. 8.15 Apotex
  86. 8.15.1 Apotex Company Information
  87. 8.15.2 Apotex Business Overview
  88. 8.15.3 Apotex Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Apotex Teriflunomide Tablets Product Portfolio
  90. 8.15.5 Apotex Recent Developments
  91. 8.16 Alembic
  92. 8.16.1 Alembic Company Information
  93. 8.16.2 Alembic Business Overview
  94. 8.16.3 Alembic Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Alembic Teriflunomide Tablets Product Portfolio
  96. 8.16.5 Alembic Recent Developments
  97. 8.17 Accord Healthcare
  98. 8.17.1 Accord Healthcare Company Information
  99. 8.17.2 Accord Healthcare Business Overview
  100. 8.17.3 Accord Healthcare Teriflunomide Tablets Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Accord Healthcare Teriflunomide Tablets Product Portfolio
  102. 8.17.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Teriflunomide Tablets Value Chain Analysis
  2. 9.1.1 Teriflunomide Tablets Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Teriflunomide Tablets Sales Mode & Process
  6. 9.2 Teriflunomide Tablets Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Teriflunomide Tablets Distributors
  9. 9.2.3 Teriflunomide Tablets Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst